Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review

Ansari, J., Eltigani Mohmmed, Y., Ghazal-Aswad, S. et al. (15 more authors) (2021) Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review. Gynecologic Oncology Reports, 38. 100878. ISSN 2352-5789

Abstract

Metadata

Authors/Creators:
  • Ansari, J.
  • Eltigani Mohmmed, Y.
  • Ghazal-Aswad, S.
  • Ansari, H.
  • Akhter, S.M.J.
  • Hassoun Hadid, O.
  • Rizwan, S.
  • Almazrouei, R.
  • Dawoud, E.
  • Azribi, F.
  • Elhasin, H.
  • Kumar, P.
  • Al Sumaida, A.R.
  • Al-Qawasmeh, K.
  • Glaholm, J.
  • Hochmair, M.J.
  • Hussain, S. ORCID logo https://orcid.org/0000-0003-1552-511X
  • Balaraj, K.
Copyright, Publisher and Additional Information: © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Pembrolizumab; Vaginal squamous cell carcinoma; Radiotherapy; Immune related adverse events; Wall-eyed internuclear ophthalmoplegia; Checkpoint inhibitors
Dates:
  • Accepted: 4 October 2021
  • Published (online): 8 October 2021
  • Published: November 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 11 May 2022 15:40
Last Modified: 13 May 2022 04:07
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.gore.2021.100878
Related URLs:

Share / Export

Statistics